Evonik Evonik

X

Find Vixotrigine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Vixotrigine
Also known as: 934240-30-9, Vixotrigine, Cnv1014802, Gsk1014802, Cnv-1014802, Gsk-1014802
Molecular Formula
C18H19FN2O2
Molecular Weight
314.4  g/mol
InChI Key
JESCETIFNOFKEU-SJORKVTESA-N
FDA UNII
QQS4J85K6Y

Raxatrigine has been investigated for the treatment of Bipolar Disorder and Bipolar Depression.
1 2D Structure

Vixotrigine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S,5R)-5-[4-[(2-fluorophenyl)methoxy]phenyl]pyrrolidine-2-carboxamide
2.1.2 InChI
InChI=1S/C18H19FN2O2/c19-15-4-2-1-3-13(15)11-23-14-7-5-12(6-8-14)16-9-10-17(21-16)18(20)22/h1-8,16-17,21H,9-11H2,(H2,20,22)/t16-,17+/m1/s1
2.1.3 InChI Key
JESCETIFNOFKEU-SJORKVTESA-N
2.1.4 Canonical SMILES
C1CC(NC1C2=CC=C(C=C2)OCC3=CC=CC=C3F)C(=O)N
2.1.5 Isomeric SMILES
C1C[C@H](N[C@H]1C2=CC=C(C=C2)OCC3=CC=CC=C3F)C(=O)N
2.2 Other Identifiers
2.2.1 UNII
QQS4J85K6Y
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Biib074

2. Cnv1014802

3. Vixotrigine

2.3.2 Depositor-Supplied Synonyms

1. 934240-30-9

2. Vixotrigine

3. Cnv1014802

4. Gsk1014802

5. Cnv-1014802

6. Gsk-1014802

7. Biib074

8. Cnv 1014802

9. Biib-074

10. Vixotrigine [usan]

11. Raxatrigine (gsk1014802)

12. (2s,5r)-5-(4-((2-fluorobenzyl)oxy)phenyl)pyrrolidine-2-carboxamide

13. Gsk 1014802

14. Qqs4j85k6y

15. Gsk1014802(cnv1014802)

16. 934240-30-9 (free Base).

17. 2-pyrrolidinecarboxamide, 5-(4-((2-fluorophenyl)methoxy)phenyl)-, (2s,5r)-

18. 2-pyrrolidinecarboxamide, 5-[4-[(2-fluorophenyl)methoxy]phenyl]-, (2s,5r)-

19. Raxatrigine [usan]

20. Gsk2

21. Unii-qqs4j85k6y

22. Biib 074

23. (2s,5r)-5-[4-[(2-fluorophenyl)methoxy]phenyl]pyrrolidine-2-carboxamide

24. (2s,5r)-5-(4-((2-fluorophenyl)methoxy)phenyl)pyrrolidine-2-carboxamide

25. Biib 074,vixotrigine

26. Vixotrigine [inn]

27. Vixotrigine (usan/inn)

28. Vixotrigine [who-dd]

29. Schembl310473

30. Chembl3544913

31. Dtxsid901031867

32. (5r)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-l-prolinamide

33. Ex-a2232

34. Bdbm50505255

35. Zinc34892269

36. Akos027324140

37. Db11706

38. Ncgc00386656-01

39. Ac-31665

40. As-56210

41. Hy-12796

42. Cnv1014802; Gsk-1014802; Raxatrigine

43. D11179

44. N11408

45. A857124

46. (5r)-5-(4-[2-fluorobenzyloxy]phenyl)-l-prolinamide

47. Q18386159

48. (2s,5r)-5-(4-(2-fluorobenzyloxy)phenyl)pyrrolidine-2-carboxamide

49. (5r)-5-{4-[(2-fluorobenzyl)oxy]phenyl}-l-prolinamide;cnv1014802

2.4 Create Date
2007-04-30
3 Chemical and Physical Properties
Molecular Weight 314.4 g/mol
Molecular Formula C18H19FN2O2
XLogP32.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Exact Mass314.14305602 g/mol
Monoisotopic Mass314.14305602 g/mol
Topological Polar Surface Area64.4 Ų
Heavy Atom Count23
Formal Charge0
Complexity399
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY